The Therapeutic Landscape in Chronic Cough-Reference-Cited by-同舟云学术

The Therapeutic Landscape in Chronic Cough

Published:2023-12-21 Issue: Volume: Page:
ISSN:0341-2040
Container-title:Lung
language:en
Short-container-title:Lung

Author:

Smith Jaclyn A.

Abstract

AbstractIn recent years, there has been a substantial increase in the development of antitussive therapies and the first new therapy, gefapixant has been licenced in Europe. This review describes current unlicenced treatments for chronic cough and details treatments currently in development for refractory chronic cough and cough in idiopathic pulmonary fibrosis, as well as compounds previously explored.

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00408-023-00666-y.pdf

Reference88 articles.

1. Song WJ, Chang YS, Faruqi S, Kim JY, Kang MG, Kim S et al (2015) The global epidemiology of chronic cough in adults: a systematic review and meta-analysis. Eur Respir J 45(5):1479–81

2. Colak Y, Nordestgaard BG, Laursen LC, Afzal S, Lange P, Dahl M (2017) Risk factors for chronic cough among 14,669 individuals from the general population. Chest 152(3):563–73

3. Morice AH, Millqvist E, Bieksiene K, Birring SS, Dicpinigaitis P, Domingo Ribas C et al (2020) ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. https://doi.org/10.1183/13993003.01136-2019

4. Saunders P, Wu Z, Fahy WA, Stewart ID, Saini G, Smith DJF et al (2023) The burden and impact of cough in patients with idiopathic pulmonary fibrosis: an analysis of the prospective observational PROFILE study. Ann Am Thorac Soc 20(9):1267–73

5. Key AL, Holt K, Hamilton A, Smith JA, Earis JE (2010) Objective cough frequency in idiopathic pulmonary fibrosis. Cough 6:4

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current opinion in refractory and/or unexplained chronic cough;Current Opinion in Otolaryngology & Head & Neck Surgery;2024-09-05

2. Finely ordered intracellular domain harbors an allosteric site to modulate physiopathological function of P2X3 receptors;Nature Communications;2024-09-03

3. The discovery and development of gefapixant as a novel antitussive therapy;Expert Opinion on Drug Discovery;2024-08-13

4. Burden of Disease Associated with Refractory and Unexplained Chronic Cough in Canada: Results from a National Survey;Lung;2024-06-12

5. Chronic cough: New guidelines, new approaches and new treatments;Respirology;2024-02-27